Effect of Methylphenidate on Cancer-related Cognitive Impairment
Stopped We decided to close recruitment in December 2022 as we were having trouble recruiting participants who met our inclusion criteria and the study funding was coming to an end.
Conditions
- Breast Cancer Female
- Cancer-Related Condition
Interventions
- DRUG: Methylphenidate HCl 10Mg SR
- DRUG: Placebo Group
Sponsor
CHU de Quebec-Universite Laval
Collaborators
- [object Object]
- [object Object]
- [object Object]